Please note that eDoc will be permanently shut down in the first quarter of 2021!      Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für molekulare Genetik     Collection: Research Group Development and Disease     Display Documents



  history
ID: 334846.0, MPI für molekulare Genetik / Research Group Development and Disease
Extensive molecular genetic analysis of the 3p14.3 region in patients with Zimmermann-Laband syndrome.
Authors:Abo-Dalo, Benjamin; Kim, Hyung-Goo; Roes, Melanie; Stefanova, Margarita; Higgins, Anne; Shen, Yiping; Mundlos, Stefan; Quade, Bradley J.; Gusella, James F.; Kutsche, Kerstin
Language:English
Research Context:Funded by: Deutsche Forschungsgemeinschaft; Grant Number: GRK336, KU 1240/3-1, 3-2, DAAD; Grant Number: DAAD 07/2005 and USPHS; Grant Number: GM061354, HD28138
Date of Publication (YYYY-MM-DD):2007-10-15
Title of Journal:American Journal of Medical Genetics / Part A
Journal Abbrev.:Am. J. Med. Genet.
Volume:143
Issue / Number:22
Start Page:2668
End Page:2674
Copyright:© 2007 Wiley-Liss, Inc.
Review Status:not specified
Audience:Experts Only
Abstract / Description:Zimmermann-Laband syndrome (ZLS) is a rare autosomal dominant inherited disorder characterized by a coarse facial appearance, gingival fibromatosis, and absence or hypoplasia of the terminal phalanges and nails of hands and feet. Additional, more variable features include hyperextensibility of joints, hepatosplenomegaly, mild hirsutism, and mental retardation. Mapping of the translocation breakpoints of t(3;8) and t(3;17) found in patients with the typical clinical features of ZLS defined a common breakpoint region of 280 kb located in 3p14.3, which includes the genes CACNA2D3 and WNT5A. Breakpoint cloning revealed that both translocations most likely occurred by non-homologous (illegitimate) recombination. Mutation analysis of nine genes located in 3p21.1-p14.3, including CACNA2D3, which is directly disrupted by one breakpoint of the t(3;17), identified no pathogenic mutation in eight sporadic patients with ZLS. Southern hybridization analysis and multiplex ligation-dependent probe amplification (MLPA) did not detect submicroscopic deletion or duplication in either CACNA2D3 or WNT5A in ZLS-affected individuals. Mutation analysis of nine conserved nongenic sequence elements (CNEs) in 3p21.1-p14.3, which were identified by interspecies comparison and may represent putative regulatory elements for spatiotemporally correct expression of nearby genes, did not show any sequence alteration associated with ZLS. Taken together, the lack of a specific coding-sequence lesion in the common region, defined by two translocation breakpoints, in sporadic patients with ZLS and an apparently normal karyotype suggests that either some other type of genetic defect in this vicinity or an alteration elsewhere in the genome could be responsible for ZLS.


This article contains supplementary material, which may be viewed at the American Journal of Medical Genetics website at http://www.interscience.wiley.com/jpages/1552-4825/suppmat/index.html .
Free Keywords:Zimmermann-Laband syndrome • WNT5A • CACNA2D3 • chromosome translocation • gingival hyperplasia
Comment of the Author/Creator:email: Kerstin Kutsche (kkutsche@uke.uni-hamburg.de)
Correspondence to Kerstin Kutsche, Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Campus Forschung, Gebäude 146, Martinistraße 52, D-20246 Hamburg, Germany.
External Publication Status:published
Document Type:Article
Version Comment:Automatic journal name synchronization
Communicated by:Stefan Mundlos
Affiliations:MPI für molekulare Genetik
External Affiliations:1.Institut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany;
2.Molecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital/Department of Genetics, Harvard Medical School, Massachusetts, USA;
3.Department of Medical Genetics, Medical University, Plovdiv, Bulgaria;
4.Department of Pathology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Identifiers:ISSN:0148-7299
DOI:10.1002/ajmg.a.32034
URI:http://www3.interscience.wiley.com/cgi-bin/fulltex...
Full Text:
Sorry, no privileges
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.